iNova Pharmaceuticals’s $13.5 million Acquisition of Probiotec’s Gold Cross, David Craig and Skin Basics brands

Arnold Bloch Leibler advised ASX-listed Probiotec Limited on the deal Probiotec executed an agreement to sell pharmaceutical brands Gold Cross, David Craig and Skin Basics, including...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Stella Natural Resources Inc.’s Joint Venture agreement with Australian Pacific Coal Limited

Corrs Chambers Westgarth, has advised Canadian headquartered Stella Natural Resources Inc (SNR) in relation to the recently announced agreement with Australian Pacific Coal Limited (AQC) to...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Shanghai Pharmaceuticals’ Joint Venture with Phililab to Launch Its First Overseas R&D Center

Sidley has advised Shanghai Pharmaceuticals Holding Co. Ltd. (HKEX: 2607) (SSE: 601607) (SPH) on its joint venture with Phililab, Inc. (Phililab) through its Delaware subsidiary, SPH...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here